HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.

Abstract : In order to clarify the role of HMW FGF-2 in glioma development and angiogenesis, we over-expressed different human FGF-2 isoforms in C6 rat glioma cell line using a tetracycline-regulated expression system. Phenotypic modifications were analyzed in vitro and compared to untransfected cells or to cells over-expressing 18 kDa FGF-2 or all FGF-2 isoforms. In particular, we demonstrate that HMW FGF-2 has unique features in inhibiting glioma cell proliferation. HMW FGF-2 expressing cells showed a cell-cycle arrest at the G2M, demonstrating a role of HMW FGF-2 in controlling the entry in mitosis. Moreover, hydroxyurea was ineffective in blocking cells at the G1S boundary when HMW FGF-2 was expressed. We also show that the HMW FGF-2 isoforms inhibit 4E-BP1 phosphorylation at critical sites restoring the translation inhibitory activity of 4E-BP1. In vivo, inhibition of tumor growth was observed when cells expressed HMW FGF-2. This indicates that HMW FGF-2 inhibits tumor growth in glioma cells by acting on cell-cycle progression and protein translation.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-00409173
Contributor : Marie Francoise Simon Connect in order to contact the contributor
Submitted on : Thursday, August 6, 2009 - 1:27:53 PM
Last modification on : Friday, January 10, 2020 - 9:09:08 PM

Links full text

Identifiers

Collections

Citation

Sylvie Lemiere, Rania Azar, Francis Belloc, Demir Gürsel, Stéphane Pyronnet, et al.. Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.. Experimental Cell Research, Elsevier, 2008, 314 (20), pp.3701-11. ⟨10.1016/j.yexcr.2008.09.022⟩. ⟨inserm-00409173⟩

Share

Metrics

Record views

83